{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:46:19Z","timestamp":1785800779319,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-024-00860-8","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T07:02:15Z","timestamp":1709190135000},"page":"373-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A case of non-lupus full-house nephropathy diagnosed by kidney biopsy but observed IgA nephropathy on second biopsy"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0475","authenticated-orcid":false,"given":"Yoichi","family":"Iwafuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiei","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"860_CR1","first-page":"190","volume-title":"Diagnostic pathology kidney diseases","author":"I Bajema","year":"2015","unstructured":"Bajema I, Rijnink E. Idiopathic nonlupus full-house nephropathy. In: Colvin RB, Chang A, editors. Diagnostic pathology kidney diseases. 3rd ed. Philadelphia: Elsevier; 2015. p. 190\u20131.","edition":"3"},{"issue":"8","key":"860_CR2","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s004670050681","volume":"13","author":"A Gianviti","year":"1999","unstructured":"Gianviti A, Barsotti P, Barbera V, Faraggiana T, Rizzoni G. Delayed onset of systemic lupus erythematosus in patients with \u201cfull-house\u201d nephropathy. Pediatr Nephrol. 1999;13(8):683\u20137.","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"860_CR3","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013010026","volume":"24","author":"M Lech","year":"2013","unstructured":"Lech M, Anders HJ. The pathogenesis of lupus nephritis. J Am Soc Nephrol. 2013;24(9):1357\u201366.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"860_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ajcp\/78.1.29","volume":"78","author":"E Jones","year":"1982","unstructured":"Jones E, Magil A. Nonsystemic mesangiopathic glomerulonephritis with \u201cfull house\u201d immunofluorescence: pathological and clinical observations in five patients. Am J Clin Pathol. 1982;78(1):29\u201334.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"860_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ajcp\/79.2.273","volume":"79","author":"M Miura","year":"1983","unstructured":"Miura M, Tomino Y, Nomoto Y, Endoh M, Suga T, Kaneshige H, et al. IgA nephropathy with \u201cFull House\u201d immunofluorescence. Am J Clin Pathol. 1983;79(2):273.","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"860_CR6","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/ndt\/gfx020","volume":"32","author":"EC Rijnink","year":"2017","unstructured":"Rijnink EC, Teng YK, Kraaij T, Wolterbeek R, Bruijn JA, Bajema IM. Idiopathic non-lupus full-house nephropathy is associated with poor renal outcome. Nephrol Dial Transpl. 2017;32(4):654\u201362.","journal-title":"Nephrol Dial Transpl"},{"issue":"9","key":"860_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3109\/0886022X.2010.510614","volume":"32","author":"YK Wen","year":"2010","unstructured":"Wen YK, Chen ML. Clinicopathological study of originally non-lupus \u201cfull-house\u201d nephropathy. Ren Fail. 2010;32(9):1025\u201330.","journal-title":"Ren Fail"},{"key":"860_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/289316","volume":"2013","author":"L Hongyan","year":"2013","unstructured":"Hongyan L, Yi Z, Bao D, Yuewu L, Juan M. A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review. Clin Dev Immunol. 2013;2013: 289316.","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"860_CR9","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","volume":"43","author":"NR Medjeral-Thomas","year":"2021","unstructured":"Medjeral-Thomas NR, Cook HT, Pickering MC. Complement activation in IgA nephropathy. Semin Immunopathol. 2021;43(5):679\u201390.","journal-title":"Semin Immunopathol"},{"key":"860_CR10","first-page":"463","volume-title":"Heptinstalls pathology of the kidney","author":"M Haas","year":"2015","unstructured":"Haas M. IgA nephropathy and iga vasculitis henoch-sch\u00f6nlein purpura nephritis. In: Jennette JC, Olson JL, Silva FG, D\u2019Agati VD, editors. Heptinstalls pathology of the kidney. 7th ed. Philadelphia: Wolters Kluwer; 2015. p. 463\u2013525.","edition":"7"},{"issue":"10","key":"860_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3389\/fimmu.2019.00504","volume":"19","author":"DV Rizk","year":"2019","unstructured":"Rizk DV, Maillard N, Julian BA, Knoppova B, Green TJ, Novak J, et al. The emerging role of complement proteins as a target for therapy of iga nephropathy. Front Immunol. 2019;19(10):504.","journal-title":"Front Immunol"},{"issue":"6","key":"860_CR12","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.kint.2022.07.035","volume":"102","author":"B Renner","year":"2022","unstructured":"Renner B, Laskowski J, Poppelaars F, Ferreira VP, Blaine J, Antonioli AH, et al. Factor H related proteins modulate complement activation on kidney cells. Kidney Int. 2022;102(6):1331\u201344.","journal-title":"Kidney Int"},{"issue":"19","key":"860_CR13","doi-asserted-by":"publisher","first-page":"E4433","DOI":"10.1073\/pnas.1717600115","volume":"115","author":"S Cantsilieris","year":"2018","unstructured":"Cantsilieris S, Nelson BJ, Huddleston J, Baker C, Harshman L, Penewit K, et al. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. Proc Natl Acad Sci U S A. 2018;115(19):E4433\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"860_CR14","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng1890","volume":"38","author":"AE Hughes","year":"2006","unstructured":"Hughes AE, Orr N, Esfandiary H, Diaz-Torres M, Goodship T, Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet. 2006;38(10):1173\u20137.","journal-title":"Nat Genet"},{"issue":"5","key":"860_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002079","volume":"7","author":"J Zhao","year":"2011","unstructured":"Zhao J, Wu H, Khosravi M, Cui H, Qian X, Kelly JA, et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011;7(5): e1002079.","journal-title":"PLoS Genet"},{"issue":"3","key":"860_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0030041","volume":"3","author":"PF Zipfel","year":"2007","unstructured":"Zipfel PF, Edey M, Heinen S, J\u00f3zsi M, Richter H, Misselwitz J, et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 2007;3(3): e41.","journal-title":"PLoS Genet"},{"issue":"8","key":"860_CR17","doi-asserted-by":"publisher","first-page":"e544","DOI":"10.1097\/MPH.0000000000000986","volume":"40","author":"A Nozawa","year":"2018","unstructured":"Nozawa A, Ozeki M, Hori T, Kawamoto N, Hirayama M, Azuma E, et al. A heterozygous CFHR3-CFHR1 gene deletion in a pediatric patient with transplant-associated thrombotic microangiopathy who was treated with eculizumab. J Pediatr Hematol Oncol. 2018;40(8):e544\u20136.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"11","key":"860_CR18","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1016\/j.clml.2021.06.019","volume":"21","author":"CW Freyer","year":"2021","unstructured":"Freyer CW, Bange EM, Skuli S, Hsu M, Lin J, Cuker A, et al. Carfilzomib-induced atypical hemolytic uremic syndrome in a patient with heterozygous CFHR3\/CFHR1 deletion treated with eculizumab. Clin Lymphoma Myeloma Leuk. 2021;21(11):e845\u20139.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"860_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43(4):321\u20137.","journal-title":"Nat Genet"},{"issue":"5","key":"860_CR20","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2014010096","volume":"26","author":"L Zhu","year":"2015","unstructured":"Zhu L, Zhai YL, Wang FM, Hou P, Lv JC, Xu DM, et al. Variants in complement factor h and complement factor h-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol. 2015;26(5):1195\u2013204.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"860_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002765","volume":"8","author":"K Kiryluk","year":"2012","unstructured":"Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, et al. Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012;8(6): e1002765.","journal-title":"PLoS Genet"},{"issue":"2","key":"860_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2017010019","volume":"29","author":"P Jullien","year":"2018","unstructured":"Jullien P, Laurent B, Claisse G, Masson I, Dinic M, Thibaudin D, et al. Deletion variants of cfhr1 and cfhr3 associate with mesangial immune deposits but not with progression of iga nephropathy. J Am Soc Nephrol. 2018;29(2):661\u20139.","journal-title":"J Am Soc Nephrol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00860-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T15:13:36Z","timestamp":1727795616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["860"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00860-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patient in the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}